Pindolol

吲哚洛尔

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePindolol
Drug Alias Name吲跺心安pindololPindololum品多洛尔心得静 +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors antagonists
TargetsAdrenergic receptors
Therapy Area/IndicationsMood DisordersAmphetamine-Related DisordersSubstance-Related Disorders +[8] 
Global Approved IndicationsEssential HypertensionHypertensionAngina Pectoris +[5] 
Approved Indications in ChinaHypertensionAngina PectorisArrhythmias, Cardiac
Original Approved Country/TerritoryJapan
Original Approved Date1980/06/19
Country/TerritoryUnited StatesSwitzerlandMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesNichi-Iko Pharmaceutical Co Ltd
Inactive CompaniesHeffter Research InstituteNovartis Pharma Ag
Active IndicationsEssential HypertensionHypertensionAngina Pectoris +[5] 
Inactive IndicationsMood DisordersAmphetamine-Related DisordersSubstance-Related Disorders

Other Information

ATC CodeC07AA03
Related LinksWikipediaDrugBankKEGG